Behavioral effects of rolipram and structurally related compounds in mice: Behavioral sedation of cAMP phosphodiesterase inhibitors

Pharmacology, Biochemistry and Behavior

Volumn 39, Issue 2, 1991, Pages 321-323

  Griebel, Guy ^a   Misslin, René ^a   Vogel, Elise ^a   Bourguignon, Jean Jacques ^b  

^a Laboratoire de Psychophysiologie   (France)

^b CENTRE DE NEUROCHIMIE   (France)

Author keywords

Adenine; Anxiolysis; cAMP phosphodiesterase inhibitors; Locomotion; Mice; Rears; Rolipram; Sedation

Indexed keywords

4 (3,4 DIMETHOXYPHENYL) 2 PYRROLIDONE; 6 (3 CYCLOPENTYLOXY 4 METHOXYPHENYL) 4,5 DIHYDRO 3(2H) PYRIDAZINONE; 9 (2 FLUOROBENZYL) 6 N METHYLADENINE; AAL 122; AAL 250; CYCLIC AMP; ROLIPRAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANXIETY; ARTICLE; BEHAVIOR; CONTROLLED STUDY; INTRAPERITONEAL DRUG ADMINISTRATION; LOCOMOTION; MALE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SEDATION;

3',5'-CYCLIC-NUCLEOTIDE PHOSPHODIESTERASE; ANIMAL; BEHAVIOR, ANIMAL; CONFLICT (PSYCHOLOGY); DOSE-RESPONSE RELATIONSHIP, DRUG; EXPLORATORY BEHAVIOR; HYPNOTICS AND SEDATIVES; MALE; MICE; MOTOR ACTIVITY; PHOSPHODIESTERASE INHIBITORS; PURINES; PYRROLIDINONES; ROLIPRAM;

EID: 0025777210     PISSN: 00913057     EISSN: None     Source Type: Journal    
DOI: 10.1016/0091-3057(91)90186-6     Document Type: Article

References (20)

1. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors
2. Anxiogenic effects of methyl-β-carboline-3-carboxylate in a light/dark choice situation
3. Preliminary report of a simple animal behavior model for the anxiolytic effects of benzodiazepines
4. Assessment of selective inhibition of rat cerebral cortical calcium-independent and calcium-dependent phosphodiesterases in crude extracts using deoxycyclic AMP and potassium ions
5. Clinical effects of the neurotropic-selective cAMP phosphodiesterase inhibitor rolipram in depressed patients: Global evaluation on preliminary reports
6. 3H]rolipram
7. Behavioural validation of a light/dark choice procedure for testing anti-anxiety agents
8. Selective inhibition of one of the cyclic AMP phosphodiesterase from rat brain by the neurotropic compound rolipram
9. Antidepressant effects of rolipram in a genetic animal model of depression: Cholinergic supersensitivity and weight gain
10. The effect of various centrally active drugs on adenosine uptake by the central nervous system
11. Stereospecific binding of the antidepressant rolipram to brain protein structures
12. Rolipram, a stereospecific inhibitor of calmodulin-independent phosphodiesterase, causes β-adrenoceptor subsensitivity in rat cerebral cortex
13. 4-(3-Cyclopentyloxy-4-methoxyphenyl)-2-pyrrolidone (ZK 62711): A potent inhibitor of adenosine cyclic 3′, 5′-monophosphate phosphodiesterase in homogenates and tissue slices from rat brain
14. Synthesis and enzymic activity of various substituted pyrazolo[1,5-a]-1,3,5-triazines as adenosine cyclic 3′,5′-phosphate phosphodiesterase inhibitors
15. Characteristic behavioral alterations in rats induced by rolipram and other selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitors
16. Neurotropic effects of the optical isomers of the selective adenosine cyclic 3′,5′-monophosphate phosphodiesterase inhibitor rolipram in rats in-vivo
17. Potential antidepressant activity of rolipram and other selective cyclic adenosine 3′,5′-monophosphate phosphodiesterase inhibitors
18. Anxiolytic and sedative properties of BW A78U, a novel anticonvulsant adenine derivative